Kursprognose für ProQR Therapeutics NV (PRQR)PRQRProQR Therapeutics NV

Alphio's PRQR stock price prediction model matches the current ProQR Therapeutics NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.33 (-0.23%). The 1-week path is $1.35 (+1.24%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

ProQR Therapeutics is currently trading at $1.32, significantly below its 52-week high of $2.65, indicating potential upside. However, the stock has a low RSI of 39.15, suggesting it is nearing oversold territory, but it also reflects weak momentum. The company has a gross margin of 100%, which is excellent, but it has reported consistent net losses, with a net income loss of €13,383,000 in Q1 2026. The main risk is the company's ongoing financial losses and reliance on external financing, as evidenced by a recent direct offering that caused a 20% drop in share price. Given these factors, it may be prudent to hold rather than buy at this time, as the stock may need to stabilize before a clear buying opportunity arises.

ProQR Therapeutics NV (PRQR) last closed at $1.335, losing -5.32%. These facts feed the 1-day and 1-week PRQR price prediction above.